Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDIK1L | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | NGB | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | FAM184B | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | REEP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | MAP1B | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | PIDD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | TSHZ1 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | ZIC3 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | FLRT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |